Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T18:52:36.464Z.
Calculation as of: 2026-10-06T18:52:36.464Z.
Quote observation: 2026-10-06T18:49:49.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e2377adf8a67d9885493687def1e39da55984393789cfa4a1880694b5c46c4a2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-05-10.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
0.19x
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$447.77M
EV/EBIT Ratio
N/A
TTM Avg
84.81x
3Y Avg
33.20x
5Y Avg
21.83x
Market Cap
$443.12M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | $448.87M | N/A | 0.19x | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $447.77M | N/A | 84.81x | 33.20x | 21.83x |
| NeuroPace, Inc. (NPCE)vs › | $442.54M | N/A | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $443.12M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $455.92M | 36.82x | 22.84x | 18.67x | 19.86x |
| Tectonic Therapeutic, Inc. (TECX)vs › | $437.37M | N/A | N/A | N/A | N/A |
| Assembly Biosciences, Inc. (ASMB)vs › | $437.47M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $428.85M | N/A | 64.08x | 60.43x | 132.37x |
| Editas Medicine, Inc. (EDIT)vs › | $430.46M | N/A | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $470.02M | N/A | 5.92x | 17.76x | 17.76x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2022-05-10 | 0.01x |
| 2022-05-09 | 0.04x |
| 2022-05-06 | 0.04x |
| 2022-05-05 | 0.08x |
| 2022-05-04 | 0.17x |
| 2022-05-03 | 0.14x |
| 2022-05-02 | 0.08x |
| 2022-04-28 | 0.02x |
| 2022-04-27 | 0.01x |
| 2022-04-26 | 0.05x |
| 2022-04-25 | 0.10x |
| 2022-04-22 | 0.10x |
| 2022-04-21 | 0.19x |
| 2022-04-20 | 0.22x |
| 2022-04-19 | 0.22x |
| 2022-04-18 | 0.24x |
| 2022-04-14 | 0.25x |
| 2022-04-13 | 0.28x |
| 2022-04-12 | 0.24x |
| 2022-04-11 | 0.24x |
| 2022-04-08 | 0.26x |
| 2022-04-07 | 0.26x |
| 2022-04-06 | 0.28x |
| 2022-04-05 | 0.29x |
| 2022-04-04 | 0.30x |
| 2022-04-01 | 0.25x |
| 2022-03-31 | 0.21x |
| 2022-03-30 | 0.23x |
| 2022-03-29 | 0.32x |
| 2022-03-28 | 0.26x |
| 2022-03-25 | 0.26x |
| 2022-03-24 | 0.21x |
| 2022-03-23 | 0.24x |
| 2022-03-22 | 0.26x |
| 2022-03-21 | 0.14x |
| 2022-03-18 | 0.25x |
| 2022-03-17 | 0.22x |
| 2022-03-16 | 0.18x |
| 2022-03-15 | 0.08x |
| 2022-03-14 | 0.12x |
| 2022-03-11 | 0.22x |
| 2022-03-10 | 0.27x |
| 2022-03-09 | 0.25x |
| 2022-03-08 | 0.21x |
| 2022-03-07 | 0.19x |
| 2022-03-04 | 0.19x |
| 2022-03-03 | 0.17x |
| 2022-03-02 | 0.25x |
| 2022-03-01 | 0.23x |
| 2022-02-28 | 0.22x |
| 2022-02-25 | 0.16x |
| 2022-02-24 | 0.12x |
| 2022-02-23 | 0.05x |
| 2022-02-22 | 0.13x |
| 2022-02-18 | 0.13x |
| 2022-02-17 | 0.13x |
| 2022-02-16 | 0.12x |
| 2022-02-15 | 0.13x |
| 2022-02-14 | 0.11x |
| 2022-02-11 | 0.09x |
| 2022-02-10 | 0.10x |
| 2022-02-09 | 0.11x |
| 2022-02-08 | 0.02x |
| 2022-01-21 | 0.07x |
| 2022-01-20 | 0.09x |
| 2022-01-19 | 0.04x |
| 2022-01-18 | 0.04x |
| 2022-01-14 | 0.08x |
| 2022-01-13 | 0.12x |
| 2022-01-12 | 0.12x |
| 2022-01-11 | 0.11x |
| 2022-01-10 | 0.10x |
| 2022-01-07 | 0.17x |
| 2022-01-06 | 0.18x |
| 2022-01-05 | 0.23x |
| 2022-01-04 | 0.27x |
| 2022-01-03 | 0.21x |
| 2021-12-31 | 0.13x |
| 2021-12-30 | 0.11x |
| 2021-12-29 | 0.09x |
| 2021-12-28 | 0.14x |
| 2021-12-27 | 0.18x |
| 2021-12-23 | 0.22x |
| 2021-12-22 | 0.16x |
| 2021-12-21 | 0.15x |
| 2021-12-20 | 0.16x |
| 2021-12-17 | 0.15x |
| 2021-12-16 | 0.08x |
| 2021-12-15 | 0.13x |
| 2021-12-14 | 0.16x |
| 2021-12-13 | 0.13x |
| 2021-12-10 | 0.15x |
| 2021-12-09 | 0.16x |
| 2021-12-08 | 0.21x |
| 2021-12-07 | 0.23x |
| 2021-12-06 | 0.14x |
| 2021-12-03 | 0.13x |
| 2021-12-02 | 0.14x |
| 2021-12-01 | 0.14x |
| 2021-11-30 | 0.20x |
| 2021-11-29 | 0.17x |
| 2021-11-26 | 0.15x |
| 2021-11-24 | 0.18x |
| 2021-11-23 | 0.18x |
| 2021-11-22 | 0.24x |
| 2021-11-19 | 0.25x |
| 2021-11-18 | 0.21x |
| 2021-11-17 | 0.29x |
| 2021-11-16 | 0.31x |
| 2021-11-15 | 0.35x |
| 2021-11-12 | 0.31x |
| 2021-11-11 | 0.28x |
| 2021-11-10 | 0.20x |
| 2021-11-09 | 0.26x |
| 2021-11-08 | 0.27x |
| 2021-11-05 | 0.25x |
| 2021-11-04 | 0.30x |
| 2021-11-03 | 0.28x |
| 2021-11-02 | 0.21x |
| 2021-11-01 | 0.18x |
| 2021-10-29 | 0.15x |
| 2021-10-28 | 0.15x |
| 2021-10-27 | 0.18x |
| 2021-10-26 | 0.20x |
| 2021-10-25 | 0.22x |
| 2021-10-22 | 0.25x |
| 2021-10-21 | 0.27x |
| 2021-10-20 | 0.27x |
| 2021-10-19 | 0.27x |
| 2021-10-18 | 0.23x |
| 2021-10-15 | 0.26x |
| 2021-10-14 | 0.28x |
| 2021-10-13 | 0.28x |
| 2021-10-12 | 0.33x |
| 2021-10-11 | 0.29x |
| 2021-10-08 | 0.26x |
| 2021-10-07 | 0.25x |
| 2021-10-06 | 0.17x |
| 2021-10-05 | 0.13x |
| 2021-10-04 | 0.16x |
| 2021-10-01 | 0.22x |
| 2021-09-30 | 0.13x |
| 2021-09-29 | 0.10x |
| 2021-09-28 | 0.15x |
| 2021-09-27 | 0.15x |
| 2021-09-24 | 0.18x |
| 2021-09-23 | 0.18x |
| 2021-09-22 | 0.15x |
| 2021-09-21 | 0.14x |
| 2021-09-20 | 0.12x |
| 2021-09-17 | 0.13x |
| 2021-09-16 | 0.18x |
| 2021-09-15 | 0.18x |
| 2021-09-14 | 0.15x |
| 2021-09-13 | 0.19x |
| 2021-09-10 | 0.18x |
| 2021-09-09 | 0.21x |
| 2021-09-08 | 0.21x |
| 2021-09-07 | 0.20x |
| 2021-09-03 | 0.21x |
| 2021-09-02 | 0.25x |
| 2021-09-01 | 0.24x |
| 2021-08-31 | 0.22x |
| 2021-08-30 | 0.21x |
| 2021-08-27 | 0.21x |
| 2021-08-26 | 0.18x |
| 2021-08-25 | 0.27x |
| 2021-08-24 | 0.28x |
| 2021-08-23 | 0.31x |
| 2021-08-20 | 0.21x |
| 2021-08-19 | 0.19x |
| 2021-08-18 | 0.27x |
| 2021-08-17 | 0.29x |
| 2021-08-16 | 0.33x |
| 2021-08-13 | 0.31x |
| 2021-08-12 | 0.24x |
| 2021-08-11 | 0.20x |
| 2021-08-10 | 0.16x |
| 2021-08-09 | 0.14x |
| 2021-08-06 | 0.13x |
| 2021-08-05 | 0.14x |
| 2021-08-04 | 0.10x |
| 2021-08-03 | 0.12x |
| 2021-08-02 | 0.13x |
| 2021-07-30 | 0.13x |
| 2021-07-29 | 0.15x |
| 2021-07-28 | 0.17x |
| 2021-07-27 | 0.13x |
| 2021-07-26 | 0.12x |
| 2021-07-23 | 0.14x |
| 2021-07-22 | 0.18x |
| 2021-07-21 | 0.23x |
| 2021-07-20 | 0.20x |
| 2021-07-19 | 0.10x |
| 2021-07-16 | 0.12x |
| 2021-07-15 | 0.11x |
| 2021-07-14 | 0.09x |
| 2021-07-13 | 0.19x |
| 2021-07-12 | 0.24x |
| 2021-07-09 | 0.25x |
| 2021-07-08 | 0.22x |
| 2021-07-07 | 0.20x |
| 2021-07-06 | 0.31x |
| 2021-07-02 | 0.31x |
| 2021-07-01 | 0.26x |
| 2021-06-30 | 0.24x |
| 2021-06-29 | 0.23x |
| 2021-06-28 | 0.38x |
| 2021-06-25 | 0.48x |
| 2021-06-24 | 0.46x |
| 2021-06-23 | 0.42x |
| 2021-06-22 | 0.44x |
| 2021-06-21 | 0.44x |
| 2021-06-18 | 0.50x |
| 2021-06-17 | 0.55x |
| 2021-06-16 | 0.54x |
| 2021-06-15 | 0.52x |
| 2021-06-14 | 0.55x |
| 2021-06-11 | 0.57x |
| 2021-06-10 | 0.55x |
| 2021-06-09 | 0.54x |
| 2021-06-08 | 0.54x |
| 2021-06-07 | 0.55x |
| 2021-06-04 | 0.51x |
| 2021-06-03 | 0.49x |
| 2021-06-02 | 0.53x |
| 2021-06-01 | 0.45x |
| 2021-05-28 | 0.37x |
| 2021-05-27 | 0.42x |
| 2021-05-26 | 0.33x |
| 2021-05-25 | 0.23x |
| 2021-05-24 | 0.21x |
| 2021-05-21 | 0.25x |
| 2021-05-20 | 0.20x |
| 2021-05-19 | 0.18x |
| 2021-05-18 | 0.14x |
| 2021-05-17 | 0.10x |
| 2021-05-14 | 0.05x |
